相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Statins and Diabetes: The Good, the Bad, and the Unknown
Kelly Axsom et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Mitochondrial Deficiency Is Associated With Insulin Resistance
Bret H. Goodpaster
DIABETES (2013)
Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance
Jose Mara Moreno-Navarrete et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study
Peter F. Kokkinos et al.
LANCET (2013)
Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass
Andrew G. Swick et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats
Michael D. Roberts et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Niemann-Pick C1-Like 1 and cholesterol uptake
Li-Juan Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity
Jorge Ivan Castillo-Quan
DISEASE MODELS & MECHANISMS (2012)
Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a omitohormesis' mechanism involving reactive oxygen species and PGC-1
Jamal Bouitbir et al.
EUROPEAN HEART JOURNAL (2012)
Statin induced myotoxicity
Sivakumar Sathasivam
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
Ioanna Gouni-Berthold et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes
Hyo-Bum Kwak et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Managing the underestimated risk of statin-associated myopathy
Loukianos S. Rallidis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Low Density Lipoprotein (LDL) Receptor-related Protein 6 (LRP6) Regulates Body Fat and Glucose Homeostasis by Modulating Nutrient Sensing Pathways and Mitochondrial Energy Expenditure
Wenzhong Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Physiological role of hepatic NPC1L1 in human cholesterol and lipoprotein metabolism: New perspectives and open questions
Philip N. Howles et al.
JOURNAL OF LIPID RESEARCH (2012)
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Pontus Bostroem et al.
NATURE (2012)
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
Joo Young Huh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Effect of a high dose of simvastatin on muscle mitochondrial metabolism and calcium signaling in healthy volunteers
F. Galtier et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy
Victoria C. Foletta et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2011)
Human NPC1L1 Expression is Positively Regulated by PPARα
Yuki Iwayanagi et al.
PHARMACEUTICAL RESEARCH (2011)
Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial
Kaspar Berneis et al.
EUROPEAN HEART JOURNAL (2010)
Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes
Natasa Petrovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Approach to the Patient Who Is Intolerant of Statin Therapy
Robert H. Eckel
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Beige Can Be Slimming
Jeff Ishibashi et al.
SCIENCE (2010)
The effects of ezetimibe on LDL-cholesterol: Quantitative or qualitative changes?
Manfredi Rizzo et al.
ATHEROSCLEROSIS (2009)
The effect of anti-inflammatory (aspirin and/or statin) therapy on body weight in Type 2 diabetic individuals: EAT, a retrospective study
M. Boaz et al.
DIABETIC MEDICINE (2009)
Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor γ coactivator-1α (PGC-1α)
Jae Hoon Jeong et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect
Peirang Cao et al.
FASEB JOURNAL (2009)
Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice
Eric D. Labonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: A randomized trial in healthy men
Ioanna Gouni-Berthold et al.
ATHEROSCLEROSIS (2008)
Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men
Ioanna Gouni-Berthold et al.
CLINICAL ENDOCRINOLOGY (2008)
Simvastatin vs therapeutic lifestyle changes and supplements: Randomized primary prevention trial
David J. Becker et al.
MAYO CLINIC PROCEEDINGS (2008)
SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment
H. K. Berthold et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program -: Comparative evaluation of three assays
Matthias Blueher et al.
DIABETES CARE (2007)
Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma - A randomised trial
Heiner K. Berthold et al.
DRUG SAFETY (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes
CS Mantzoros et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Safety of statins - Focus on clinical pharmacokinetics and drug interactions
S Bellosta et al.
CIRCULATION (2004)
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes
GK Shetty et al.
DIABETES CARE (2004)
分享论文
